{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:45:31Z","timestamp":1773989131353,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The c.1998delinsTTCT variant in the RET gene (codon 666) is linked to medullary thyroid carcinoma in Belgium. We aimed to study the clinical phenotype and the age-dependent penetrance in predictive variant carriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective study of index patients and predictive variant carriers, identified through familial cascade testing between 2001 and 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The total cohort comprised 119 patients: 15 index patients, 102 heterozygous, and 2 homozygous predictive variant carriers. Among heterozygous carriers, high suspicion of clinical disease was present in 25 patients at initial evaluation and in 3 patients during follow-up. No high suspicion of clinical disease was observed during surveillance in 56 patients, and 18 patients did not proceed to screening for clinical disease. Compared to index patients, surgically treated heterozygous predictive variant carriers had a lower presurgical basal calcitonin, a lower disease stage, less need for adjuvant therapy, and higher chances of remission. In heterozygous carriers, median age at developing high suspicion of disease is 52 years (range 7-75), with a predicted penetrance of 62% (9% SE) at the age of 70 years. Two patients were identified with pheochromocytoma and 1 patient with primary hyperparathyroidism. The 2 homozygous predictive variant carriers presented with higher disease severity at first clinical evaluation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The c.1998delinsTTCT variant in the RET gene is pathogenic and associated with a moderate risk for medullary thyroid carcinoma and rarely with other multiple endocrine neoplasia type 2A (MEN2A) manifestations. Active surveillance is a possible option in heterozygous gene carriers with a negative first clinical evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvad126","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:25:04Z","timestamp":1694805904000},"page":"402-408","source":"Crossref","is-referenced-by-count":3,"title":["Germline founder variant c.1998delinsTTCT in the <i>RET<\/i> oncogene: a cohort study in 15 Belgian families"],"prefix":"10.1093","volume":"189","author":[{"given":"Axelle","family":"Vuylsteke","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurens","family":"Hannes","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Brems","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Devis","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, AZ Turnhout , 2300 Turnhout , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen","family":"Renard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Uyttebroeck","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Legius","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-4757","authenticated-orcid":false,"given":"Brigitte","family":"Decallonne","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven , 3000 Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"6","key":"2023091916162665200_lvad126-B1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"2023091916162665200_lvad126-B2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-22542-5_3","article-title":"Epidemiology and clinical presentation of medullary thyroid carcinoma","volume":"204","author":"Raue","year":"2015","journal-title":"Recent Results Cancer Res"},{"issue":"4","key":"2023091916162665200_lvad126-B3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/humu.20928","article-title":"Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype\/phenotype correlations","volume":"30","author":"Margraf","year":"2009","journal-title":"Hum Mutat"},{"issue":"1","key":"2023091916162665200_lvad126-B4","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/EJE-21-0753","article-title":"GLOBAL ENDOCRINOLOGY: geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review","volume":"186","author":"Maciel","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2023091916162665200_lvad126-B5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: a review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Seminars Cancer Biol"},{"key":"2023091916162665200_lvad126-B6","first-page":"95","article-title":"Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism","volume":"16","author":"Vandenbosch","year":"2005","journal-title":"Genet Couns"},{"issue":"2","key":"2023091916162665200_lvad126-B7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1525-1578(10)60556-9","article-title":"Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases","volume":"7","author":"Ahmed","year":"2005","journal-title":"J Mol Diagn"},{"issue":"3","key":"2023091916162665200_lvad126-B8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1677\/erc.1.01144","article-title":"An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma","volume":"13","author":"Cordella","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2023091916162665200_lvad126-B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12020-011-9501-2","article-title":"Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family","volume":"40","author":"Mastroianno","year":"2011","journal-title":"Endocrine"},{"issue":"4","key":"2023091916162665200_lvad126-B10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/ERC-10-0306","article-title":"Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism","volume":"18","author":"Borrello","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2023091916162665200_lvad126-B11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1507\/endocrj.EJ14-0334","article-title":"A newly identified missense mutation in RET codon 666 is associated with the development of medullary thyroid carcinoma","volume":"61","author":"Yamazaki","year":"2014","journal-title":"Endocr J"},{"issue":"9","key":"2023091916162665200_lvad126-B12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jamasurg.2017.1665","article-title":"Rethinking the current American Joint Committee on Cancer TNM staging system for medullary thyroid cancer","volume":"152","author":"Adam","year":"2017","journal-title":"JAMA Surg"},{"issue":"7","key":"2023091916162665200_lvad126-B13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.oraloncology.2013.03.443","article-title":"Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging","volume":"49","author":"Tuttle","year":"2013","journal-title":"Oral Oncol"},{"issue":"6","key":"2023091916162665200_lvad126-B14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EC-18-0157","article-title":"Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study","volume":"7","author":"Mathiesen","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"2023091916162665200_lvad126-B15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","article-title":"Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years","volume":"161","author":"Randle","year":"2017","journal-title":"Surgery"},{"issue":"4","key":"2023091916162665200_lvad126-B16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/annonc\/mdq467","article-title":"Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects","volume":"22","author":"Maso L","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"2023091916162665200_lvad126-B17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1055-9965.EPI-08-0960","article-title":"Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005","volume":"18","author":"Enewold","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2023091916162665200_lvad126-B18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1089\/thy.2012.0532","article-title":"Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008","volume":"23","author":"Veiga","year":"2013","journal-title":"Thyroid"},{"issue":"11","key":"2023091916162665200_lvad126-B19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2217\/fon.10.127","article-title":"Thyroid cancer gender disparity","volume":"6","author":"Rahbari","year":"2010","journal-title":"Future Oncol"},{"issue":"6","key":"2023091916162665200_lvad126-B20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad126\/51607853\/lvad126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/3\/402\/51684930\/lvad126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/3\/402\/51684930\/lvad126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:03:09Z","timestamp":1695142989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/3\/402\/7275010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad126","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9,1]]}}}